Bristol Myers and Bluebird bio win FDA approval for ide-cel in multiple myeloma
March 26 2021 - 11:40PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Mar 2024 to Apr 2024
bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Apr 2023 to Apr 2024